CD8A and non-small cell lung carcinoma: In this research, our findings indicated that YTHDF3 up-regulation impaired the CD8+ T antitumor activity to deteriorate NSCLC immune evasion, while YTHDF3 silencing recovered the CD8+ T antitumor activity to inhibit immune evasion.